Current Radiopharmaceuticals
Title:Editorial Review 2017
Volume: 10 Issue: 1
Author(s): Sean L. Kitson and Luigi Mansi
Affiliation:
Export Options
About this article
Cite this article as:
L. Kitson Sean and Mansi Luigi , Editorial Review 2017, Current Radiopharmaceuticals 2017; 10 (1) . https://dx.doi.org/10.2174/187447101001170309162941
DOI https://dx.doi.org/10.2174/187447101001170309162941 |
Print ISSN 1874-4710 |
Publisher Name Bentham Science Publisher |
Online ISSN 1874-4729 |
17
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Detection of Predictive Markers for Therapeutic Stratification of Salivary Glands Tumors
Current Drug Targets Skeletal Muscle Protein Balance and Metabolism in the Elderly
Current Aging Science Glutathione Peroxidase: A Potential Marker for the Most Common Diseases and Disorders
Recent Patents on Biomarkers Structure-Based Approach for the Discovery of Novel Selective Estrogen Receptor Modulators
Current Medicinal Chemistry Heat Shock Proteins: Therapeutic Perspectives in Inflammatory Disorders
Recent Patents on Inflammation & Allergy Drug Discovery Editorial (Thematic Issue: “Molecular Profiling and Ways Towards Personalized Medicine in Advanced Differentiated Thyroid Cancer”)
Current Genomics Cigarette Smoke-Induced Proteostasis Imbalance in Obstructive Lung Diseases
Current Molecular Medicine Polypharmacological Properties and Therapeutic Potential of β-Caryophyllene: A Dietary Phytocannabinoid of Pharmaceutical Promise
Current Pharmaceutical Design Editorial Review of 2014
Current Radiopharmaceuticals Glutamine, Glucose and other Fuels for Cancer
Current Pharmaceutical Design Small Molecule Kinase Inhibitors as Anti-Cancer Therapeutics
Mini-Reviews in Medicinal Chemistry HDAC as a Therapeutic Target for Treatment of Endometrial Cancers
Current Pharmaceutical Design Medical Expert Systems
Current Bioinformatics NF-κB Inhibitors in Head and Neck Cancer
Letters in Drug Design & Discovery Epigenetic Remodeling of Chromatin Architecture: Exploring Tumor Differentiation Therapies in Mesenchymal Stem Cells and Sarcomas
Current Stem Cell Research & Therapy Vascular Endothelial Growth Factor Receptors [VEGFR] as Target in Breast Cancer Treatment: Current Status in Preclinical and Clinical Studies and Future Directions
Current Topics in Medicinal Chemistry Recent Patents in Circulating Cell-Free Tumor DNA as Biomarker in Cancer
Recent Patents on Biomarkers Celiac Disease: Pathogenesis and Novel Therapeutic Strategies
Endocrine, Metabolic & Immune Disorders - Drug Targets Merlin, a “Magic” Linker Between the Extracellular Cues and Intracellular Signaling Pathways that Regulate Cell Motility, Proliferation, and Survival
Current Protein & Peptide Science Information of ADME-Associated Proteins and Potential Application for Pharmacogenetic Prediction of Drug Responses
Current Pharmacogenomics